Catalyst Wire Dossier Catalyst Wire Dossier

SYNJARDY XR

Empagliflozin, Metformin hydrochloride · Boehringer Ingelheim Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for SYNJARDY XR, covering 2016-12-09 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing